227 related articles for article (PubMed ID: 12939418)
1. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Neurology; 2003 Aug; 61(4):465-70. PubMed ID: 12939418
[TBL] [Abstract][Full Text] [Related]
2. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
4. IgG anti-Galnac-GD1a antibodies bind to neuromuscular junctions of rat hemidiaphragm.
Nagaoka T; Hotta S; Chiba T; Utsunomiya I; Abe K; Yoshino H; Koshikawa C; Taguchi K
Muscle Nerve; 2012 Nov; 46(5):705-10. PubMed ID: 23055311
[TBL] [Abstract][Full Text] [Related]
5. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-GalNAc-GD1a antibodies.
Ang CW; Yuki N; Jacobs BC; Koga M; Van Doorn PA; Schmitz PI; Van Der Meché FG
Neurology; 1999 Dec; 53(9):2122-7. PubMed ID: 10599792
[TBL] [Abstract][Full Text] [Related]
6. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
7. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
[TBL] [Abstract][Full Text] [Related]
9. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
[TBL] [Abstract][Full Text] [Related]
11. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.
Yuki N; Taki T; Handa S
J Neuroimmunol; 1996 Dec; 71(1-2):155-61. PubMed ID: 8982115
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements of anti-GD1a antibodies determine their target specificity.
Lopez PH; Zhang G; Bianchet MA; Schnaar RL; Sheikh KA
Brain; 2008 Jul; 131(Pt 7):1926-39. PubMed ID: 18487279
[TBL] [Abstract][Full Text] [Related]
13. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
[TBL] [Abstract][Full Text] [Related]
14. GalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal spinal roots.
Yoshino H; Utsunomiya I; Taguchi K; Ariga T; Nagaoka T; Aoyagi H; Asano A; Yamada M; Miyatake T
Brain Res; 2005 Sep; 1057(1-2):177-80. PubMed ID: 16154116
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.
Chatani H; Tanaka M; Nagata T; Araki T; Kusunoki S
J Clin Neurosci; 2014 Jan; 21(1):170-2. PubMed ID: 23916762
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
[TBL] [Abstract][Full Text] [Related]
17. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J
J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
[TBL] [Abstract][Full Text] [Related]
18. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
19. Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome.
Kim SY; Kim JK; Suh CK
J Clin Neurosci; 2013 Mar; 20(3):473-5. PubMed ID: 23164827
[TBL] [Abstract][Full Text] [Related]
20. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
